Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
BLCO
BLCO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BLCO News
Bausch + Lomb to Release Q1 Financial Results on April 29, 2026
5d ago
Newsfilter
Bausch + Lomb Director Acquires 4,300 Shares Amid Ownership Strategy
Mar 25 2026
Fool
Bausch + Lomb Director Increases Stock Holdings
Mar 25 2026
NASDAQ.COM
Bausch + Lomb Achieves Key Milestone in Glaucoma Treatment with ELIOS System
Mar 23 2026
seekingalpha
Bausch + Lomb Reports Positive ELIOS System Clinical Trial Results
Mar 23 2026
Newsfilter
Caspian Capital Increases Stake in Bausch + Lomb Corporation
Mar 12 2026
Fool
Caspian Capital Increases Stake in Bausch + Lomb Corporation
Mar 12 2026
NASDAQ.COM
Bausch + Lomb Launches First R&D Webinar Series
Mar 09 2026
Newsfilter
Bausch + Lomb Reports Record Q4 2025 Earnings Performance
Feb 18 2026
seekingalpha
Bausch + Lomb Q4 Earnings Beat Expectations with Revenue Growth
Feb 18 2026
seekingalpha
Bausch + Lomb Launches Fifth Annual Glaucoma Fundraising Challenge with $20,000 Match
Jan 05 2026
Newsfilter
Bausch + Lomb Completes $2.8 Billion Credit Agreement Refinancing
Jan 02 2026
Businesswire
Bausch + Lomb to Present at 2026 J.P. Morgan Healthcare Conference
Dec 23 2025
Businesswire
Bausch + Lomb Appoints Two New Directors to Accelerate Strategy
Dec 17 2025
Newsfilter
Bausch + Lomb Allocates $2.8B for Loan Refinancing
Dec 12 2025
Newsfilter
Bausch + Lomb Restructures Existing Term B Loans
Dec 12 2025
Yahoo Finance
Show More News
